Hypertrophic Cardiomyopathy

FDA Approves AI Tool for Hypertrophic Cardiomyopathy Detection

By: Dave Gilmartin

The U.S. Food and Drug Administration (FDA) has approved an artificial intelligence (AI) tool to detect and manage Hypertrophic Cardiomyopathy (HCM).

Hypertrophic Cardiomyopathy
Photomicrograph showing hypertrophic myocardium with thick muscle fibers and enlarged and dark nuclei.

The electrocardiogram (ECG) analysis software from will help identify for follow-up care potential cases of HCM, a rare condition where the heart muscle becomes thick, making it difficult for the heart to pump.

The FDA approval creates a new regulatory category for cardiovascular machine learning-based notification software, said.

“Given the high prevalence of patients with suspected HCM who remain undiagnosed, flagging and connecting them quickly to the right providers is critical to improve health outcomes,” said Matthew Martinez, MD, director of sports cardiology and HCM, Atlantic Health System. “The role of artificial intelligence in cardiology is growing exponentially and adding the HCM module to will help increase awareness and reach for HCM patients.”

The program reviews routine ECGs across a health system and notifies the care team when it identifies a potential HCM case. The new HCM module is part of 12 FDA-cleared AI algorithms on the platform used at more than 1,400 hospitals in the US and Europe, the company said.


The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.

Let Us Know What You Think

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.


More Perspectives